Condiciones de salud que psyllium puede ayudar a apoyar.
Psyllium (Plantago ovata) husk is a soluble fiber with strong systematic review evidence for improving global IBS symptoms, including abdominal discomfort. A meta-analysis found soluble fiber (psyllium) significantly improved IBS symptoms, while insoluble fiber showed no benefit. Psyllium is widely recognized by NIH, WHO, and gastroenterology guidelines for functional GI disorders.
Psyllium husk (Plantago ovata seed husk) is a soluble mucilaginous fiber that softens stools, reduces straining during defecation, and thus mechanically facilitates healing of anal fissures. High-fiber supplementation is a first-line conservative recommendation for anal fissure management in colorectal guidelines, with psyllium being the most-used fiber agent. Multiple systematic reviews support fiber supplementation as an effective conservative intervention for anal fissures.
Psyllium husk is a viscous soluble fiber that forms a large gel in the GI tract, slowing gastric emptying and promoting satiety by stimulating GLP-1 and PYY release. A systematic review and meta-analysis of RCTs confirmed viscous soluble fibers including psyllium significantly increase perceived satiety and reduce energy intake. Traditional Ayurvedic use as Isabgol for digestive regulation and satiety spans centuries.
A 2024 systematic review and dose-response meta-analysis (Food Science & Nutrition) of RCTs found that psyllium consumption significantly decreases systolic blood pressure (SBP), with the diastolic blood pressure (DBP) effect non-significant in pooled analyses. A 6-month open-label RCT in 141 hypertensive overweight patients found significant reductions in both SBP and DBP with psyllium. Effects are most consistent in patients with elevated baseline BP.
Multiple RCTs and meta-analyses demonstrate that psyllium significantly reduces fasting blood glucose and HbA1c in people with type 2 diabetes. A 2015 meta-analysis in the American Journal of Clinical Nutrition (35 RCTs) found a mean FBG reduction of −37.0 mg/dL and HbA1c reduction of −0.97% in T2DM patients dosed before meals. Effect magnitude scales with degree of glycemic dysregulation, with little effect in euglycemic individuals. Typical effective doses range from 5–15 g/day taken before meals.
Psyllium has been studied in children for both IBS-related abdominal pain and functional constipation. A randomized, double-blind trial (Shulman et al., 2016; Clinical Gastroenterology and Hepatology; 85 children aged 7–18) found that psyllium reduced the mean number of IBS pain episodes roughly twice as much as placebo over 6 weeks. Systematic reviews have also documented psyllium's efficacy for improving stool frequency and consistency in pediatric functional constipation.
Psyllium soluble fiber consistently reduces total and LDL cholesterol. A clinical study found 10.2 g/day reduced LDL-C by 7% and TC by 4% (p<0.0001) over 8 weeks. The FDA has approved a health claim for psyllium and heart disease risk reduction.
Psyllium (Plantago ovata husk) has been evaluated in clinical trials for UC maintenance and shown efficacy comparable to mesalazine for maintenance of remission in mild-to-moderate UC in at least one RCT. It acts as a prebiotic fiber, increasing butyrate-producing bacteria and fecal butyrate levels in UC patients.
Psyllium husk is a soluble, gel-forming fiber from Plantago ovata seeds with well-established clinical evidence for colon cleansing via bulk-forming laxative action. It softens stool by increasing water content in the colon, stimulates peristalsis, and normalizes bowel transit. Clinical studies support its use in constipation, IBS, and post-surgical bowel dysfunction, and it is widely included in formal colon-cleanse protocols.
Psyllium (Plantago ovata) husk is one of the most extensively studied bulk-forming laxatives for chronic constipation. FDA-approved OTC and EMA HMPC well-established use status confirmed. Multiple RCTs show significant improvements in stool frequency and consistency. AGA and ACG guidelines list psyllium fiber as a first-line recommendation for chronic idiopathic constipation.
Psyllium (from Plantago ovata husk) is a soluble dietary fiber that acts as a bulk-forming agent, absorbing water in the colon to help normalize stool consistency. It is recognized in complementary medicine references as a treatment for diarrhea, and has been studied in IBS-D to firm loose stools and reduce diarrhea frequency.
Psyllium is a soluble fiber supplement specifically recommended by multiple gastroenterological guidelines for diverticular disease management. It adds bulk to stool, reduces intraluminal colonic pressure, and promotes regular bowel movements. A 12-week clinical trial demonstrated normalization of intestinal motility and reduction of pain and flatulence in uncomplicated diverticular disease patients. UCSF and American Gastroenterological Association guidelines conditionally recommend psyllium fiber supplementation after acute diverticulitis resolves.
Psyllium fiber has been shown in clinical studies to be associated with increased GLP-1 levels and improved glycemic control. A randomized crossover study compared psyllium-enriched meals to exenatide (a GLP-1 receptor agonist) and found psyllium increased GLP-1 secretion. Meta-analyses support its role in promoting satiety.
Psyllium husk is a soluble fiber from Plantago ovata seeds with documented prebiotic effects, increasing Bifidobacterium and Lactobacillus while supporting SCFA production. Multiple human RCTs confirm its gut microbiota-modulating effects, and it is used as both a laxative and prebiotic dietary fiber.
Psyllium (Plantago ovata) husk is a soluble viscous fiber used to promote satiety and reduce caloric intake by forming a thick gel in the gastrointestinal tract. Multiple RCTs show psyllium supplementation before meals significantly increases satiety, reduces hunger, and produces modest reductions in body weight in overweight individuals.
Psyllium husk has robust clinical and regulatory support for cardiovascular health, primarily through LDL cholesterol reduction. Multiple systematic reviews and meta-analyses of randomized controlled trials confirm significant reductions in LDL-C, non-HDL cholesterol, apolipoprotein B, and blood pressure. The U.S. FDA has authorized a coronary heart disease risk-reduction health claim for psyllium since 1998, and Health Canada has issued a similar approval.
Psyllium is the most well-studied fiber supplement for hemorrhoids and is endorsed by European Society of Coloproctology guidelines. A 2006 systematic review and meta-analysis in the American Journal of Gastroenterology showed fiber supplementation (psyllium being the most studied form) reduced risk of persistent hemorrhoid symptoms by approximately 47% and hemorrhoidal bleeding by approximately 50%.
Psyllium is a soluble fiber with among the strongest evidence for IBS. Meta-analyses including over 1,400 IBS patients show improvement in global symptoms (RR 0.77) and abdominal pain (RR 0.78). A 2025 umbrella review (Nutr Rev, 175 RCTs) confirmed soluble fiber improved IBS symptoms. British Society of Gastroenterology and American College of Gastroenterology guidelines recommend soluble fiber as first-line for IBS.
Psyllium is a soluble fiber prebiotic with clinical evidence in IBD, particularly UC, where Plantago ovata seeds (the psyllium source) were found as effective as mesalazine for maintaining UC remission in a clinical trial. It supports gut microbiota, butyrate production, and intestinal transit.
Multiple RCTs and meta-analyses show psyllium significantly reduces the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), a validated marker of insulin sensitivity. A 2024 GRADE-assessed meta-analysis (19 RCTs, n=962) found a significant HOMA-IR reduction (WMD: −1.17; P<0.05). A double-blind RCT in women with PCOS also showed significant reductions in fasting insulin and HOMA1-IR and HOMA2-IR at 5 g twice daily for 8 weeks.
Psyllium is recognized as a suitable fiber supplement in chronic kidney disease (CKD) due to its low potassium and phosphorus content. Epidemiological data (NHANES III, n=14,543) link higher dietary fiber intake to reduced inflammation and CKD mortality. Preclinical CKD models show psyllium reduces serum creatinine, blood urea nitrogen, and uremic toxins (indoxyl sulfate) via the gut–kidney axis; clinical use in pre-dialysis CKD for constipation is supported by RCT evidence.
Psyllium (Plantago ovata) husk is a soluble dietary fiber with prebiotic properties that undergoes colonic fermentation to produce short-chain fatty acids including butyrate, which directly nourishes colonocytes and supports intestinal barrier integrity. Multiple authoritative sources identify psyllium as supporting gut barrier function through SCFA production and improved stool consistency reducing intestinal irritation. It has been used in multiple cultures for GI conditions for thousands of years.
Psyllium husk has robust human clinical evidence supporting its use across multiple components of metabolic syndrome (MetS). Randomized controlled trials and meta-analyses demonstrate significant reductions in LDL cholesterol, fasting blood glucose, and systolic blood pressure in MetS patients. Its gel-forming, viscous soluble fiber works via bile acid sequestration and slowed nutrient absorption, directly addressing the dyslipidemia, hyperglycemia, and hypertension that define MetS.
Psyllium is a soluble fiber recommended to help manage SIBO symptoms and support gut regularity. A narrative review published in Nutrients (2022) cited by the Institute for Natural Medicine identified psyllium as a fiber supplement that can help curb SIBO symptoms by supporting gut motility and microbiome balance without significantly increasing fermentable substrate.
Psyllium husk (Plantago ovata), a well-studied soluble fiber, has FDA-qualified health claims for cholesterol reduction and has also been shown in meta-analyses to modestly lower triglycerides in patients with metabolic syndrome and diabetes. Its high viscosity traps bile acids and reduces fat absorption.
Psyllium husk is a soluble dietary fiber that forms a gel in the intestine, bulking stool, binding toxins and waste for removal, and supporting gut microbiome health. It is the only FDA-approved dietary fiber for heart health claims and is consistently used as a foundational fiber ingredient in whole-body colon cleanse formulations.
Volver